A study of atezolizumab in combination with PEGPH20 and chemotherapy in advanced or metastatic biliary and gallbladder cancers.
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Atezolizumab (Primary) ; Hyaluronidase (Primary)
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2016 New trial record
- 10 Nov 2016 According to a Halozyme Therapeutics media release, this study is expected in the beginning of 2017.